Segall Bryant & Hamill’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.64M	Buy	+120,159	New	+$6.64M	0.09%	283
2024 Q4	–	Sell	-120,301	Closed	-$5.41M	–	628
2024 Q3	$5.41M	Buy	120,301 +1,739	+1%	+$78.3K	0.07%	317
2024 Q2	$4.11M	Buy	+118,562	New	+$4.11M	0.07%	321